Stent graft treatment for coronary sinus hemorrhage associated with esophageal cancer

Akiko Narita1, Toyohiro Ota1, Takahiro Yamamoto1

  • 1Department of Radiology, Aichi Medical University, Aichi, Japan.

Insights

Coronary sinus rupture, a rare and lethal condition, was treated with endovascular stent graft therapy in a patient with esophageal cancer. The treatment provided temporary relief but ultimately failed due to thrombosis, leading to death.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Interventional Radiology

Background:

  • Hemorrhage from the coronary sinus is exceptionally rare and often fatal.
  • Surgical intervention has been the traditional treatment for coronary sinus rupture.
  • Comorbidities can contraindicate surgery, necessitating alternative approaches.

Purpose of the Study:

  • To describe the endovascular management of coronary sinus rupture in a patient with esophageal cancer and pericardial abscess.
  • To evaluate the efficacy and limitations of stent graft deployment for this rare condition.

Main Methods:

  • A patient with coronary sinus rupture secondary to esophageal cancer and a pericardial abscess was treated with endovascular therapy.
  • Stent graft deployment was utilized to manage the hemorrhage.
  • Computed Tomography (CT) was used for follow-up imaging.

Main Results:

  • Endovascular stent graft deployment successfully controlled the hemorrhage initially, allowing for temporary patient discharge.
  • Two months post-procedure, CT revealed occlusion of the stent graft by thrombosis.
  • The patient died 2.5 months after the initial treatment due to complications, not hemorrhage.

Conclusions:

  • Endovascular therapy can be a viable alternative for coronary sinus rupture in surgically high-risk patients.
  • Thrombosis of the deployed stent graft is a significant complication that can lead to treatment failure.
  • Further research is needed to optimize endovascular strategies for managing rare vascular emergencies like coronary sinus rupture.

Related Concept Videos

Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
289
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
316
Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
939
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
353